Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fresh Tracks Therapeutics, Inc. | CEO and CFO, Director | Restricted Stock Units | 0 | $0.91 | Dec 28, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NEXI | NexImmune, Inc. | Apr 5, 2024 | 0 | $0 | 3 | Apr 10, 2024 | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney |
FRTX | Fresh Tracks Therapeutics, Inc. | Dec 28, 2023 | 1 | -$1.14K | 4 | Jan 9, 2024 | CEO and CFO, Director |
FRTX | Fresh Tracks Therapeutics, Inc. | Jan 24, 2023 | 1 | $0 | 4 | Jan 26, 2023 | Chief Financial Officer |
FRTX | Brickell Biotech, Inc. | May 5, 2022 | 1 | $0 | 4 | May 9, 2022 | Chief Financial Officer |
FRTX | Brickell Biotech, Inc. | Jun 14, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Chief Financial Officer |